IR-Med (IRME) Financial Statements
IR-Med Financial Overview
IR-Med's market cap is currently $204.49K. The company's EPS TTM is $-0.03; its P/E ratio is -0.08; IR-Med has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -21.00K | $ -17.00K | $ -10.00K | $ -5.00K | $ -1.00K |
| Operating Income | $ -1.94M | $ -4.91M | $ -4.76M | $ -3.67M | $ -730.00K |
| EBITDA | $ -1.88M | $ -4.89M | $ -4.75M | $ -3.67M | $ -729.00K |
| Net Income | $ -1.90M | $ -4.91M | $ -9.46M | $ -3.72M | $ -761.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 129.00K | $ 767.00K | $ 3.00M | $ 2.81M | $ 1.87M |
| Total Assets | $ 251.00K | $ 999.00K | $ 3.29M | $ 2.94M | $ 2.09M |
| Total Debt | $ 157.00K | $ 200.00K | $ 276.00K | $ 177.00K | $ 166.00K |
| Net Debt | $ 28.00K | $ -567.00K | $ -2.73M | $ -2.64M | $ -1.70M |
| Total Liabilities | $ 545.00K | $ 634.00K | $ 702.00K | $ 572.00K | $ 689.00K |
| Stockholders' Equity | $ -294.00K | $ 365.00K | $ 2.59M | $ 2.37M | $ 1.40M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.39M | $ -3.23M | $ -3.42M | $ -2.51M | $ -402.00K |
| Operating Cash Flow | $ -1.39M | $ -3.23M | $ -3.38M | $ -2.48M | $ -402.00K |
| Investing Cash Flow | $ 0.00 | $ -2.00K | $ -59.00K | $ -61.00K | $ 0.00 |
| Financing Cash Flow | $ 750.00K | $ 1.00M | $ 3.63M | $ 3.49M | $ 2.04M |
Currency in USD
